A prospective, observational study of long term experience in MS patients treated with cladribine
Latest Information Update: 28 Nov 2023
At a glance
- Drugs Cladribine (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2023 New trial record
- 13 Oct 2023 Results presented at the 9th Triennial joint meeting of Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis